share_log

礼来公司克罗恩病治疗药物获FDA批准

Eli Lilly and Co's drug for the treatment of Crohn's disease has been approved by the FDA.

Breakings ·  Jan 15 23:22

Eli Lilly and Co announced that its drug for the treatment of moderate to severe active Crohn's disease has been approved by the USA Food and Drug Administration (FDA). Crohn's disease is an inflammatory bowel disease that can cause chronic abdominal pain. The Indianapolis-based company stated on Wednesday that its developed drug, branded as Omvoh, is now approved in the USA for the treatment of two types of inflammatory bowel disease. The drug was previously approved in October 2023 for the treatment of adult ulcerative colitis.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
2
Comment Comment · Views 1851

Recommended

Write a comment

Statement

This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.